Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis

Jean Louis Vincent*, Herbert Spapen, Jan Bakker, Nigel R. Webster, Lloyd Curtis

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

77 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis'. Together they form a unique fingerprint.

Medicine & Life Sciences